(-)Nicotine tartrate (MP Biomedicals) was dissolved in 0.9% sterile saline and adjusted to pH 7.2–7.4 with 1 m NaOH. The final stock concentration was 0.2 mg/ml free base, which was adjusted for body weight to achieve an infusion concentration of 0.02 mg/kg/ml. CNO was purchased from Sigma-Aldrich and diluted in ACSF purchased from Tocris Biotech to 0.1 mg/ml. Heparin, xylazine (100 mg/ml), cefazolin and meloxicam used at 10 U/ml, 8 mg/kg/ml, 100 mg/kg/ml, and 1 mg/kg in 0.9% sterile saline, respectively.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.